Sherwin-Williams (NYSE:SHW) Price Target Raised to $370.00

Sherwin-Williams (NYSE:SHW - Get Free Report) had its price objective hoisted by Barclays from $355.00 to $370.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an "equal weight" rating on the specialty chemicals company's stock. Barclays's price target would indicate a potential upside of 2.39% from the company's current price.

Other equities analysts have also issued reports about the stock. Morgan Stanley upped their price target on shares of Sherwin-Williams from $375.00 to $450.00 and gave the stock an "overweight" rating in a research report on Friday, October 18th. StockNews.com upgraded shares of Sherwin-Williams from a "hold" rating to a "buy" rating in a research report on Tuesday. Wells Fargo & Company upped their target price on shares of Sherwin-Williams from $350.00 to $400.00 and gave the stock an "equal weight" rating in a research report on Tuesday, October 15th. Redburn Atlantic upgraded shares of Sherwin-Williams to a "strong-buy" rating in a research report on Thursday, July 18th. Finally, Evercore ISI increased their target price on shares of Sherwin-Williams from $365.00 to $380.00 and gave the company an "outperform" rating in a research note on Friday, August 30th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $386.29.

Sherwin-Williams Stock Performance

SHW opened at $361.38 on Wednesday. The firm has a market cap of $91.16 billion, a P/E ratio of 36.84, a PEG ratio of 3.04 and a beta of 1.17. Sherwin-Williams has a 1-year low of $232.06 and a 1-year high of $392.57. The company has a 50 day simple moving average of $371.59 and a two-hundred day simple moving average of $334.45. The company has a debt-to-equity ratio of 2.17, a current ratio of 0.81 and a quick ratio of 0.50.

Sherwin-Williams (NYSE:SHW - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing analysts' consensus estimates of $3.56 by ($0.19). The firm had revenue of $6.16 billion during the quarter, compared to the consensus estimate of $6.20 billion. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. The business's revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.20 earnings per share. Equities analysts forecast that Sherwin-Williams will post 11.49 earnings per share for the current fiscal year.

Insider Activity at Sherwin-Williams

In related news, CFO Allen J. Mistysyn sold 14,520 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $366.83, for a total value of $5,326,371.60. Following the completion of the transaction, the chief financial officer now directly owns 63,520 shares of the company's stock, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Sherwin-Williams

Hedge funds and other institutional investors have recently modified their holdings of the stock. HHM Wealth Advisors LLC raised its position in Sherwin-Williams by 102.3% during the 2nd quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company's stock worth $27,000 after buying an additional 45 shares during the last quarter. Semmax Financial Advisors Inc. raised its position in Sherwin-Williams by 136.4% during the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company's stock worth $31,000 after buying an additional 60 shares during the last quarter. VitalStone Financial LLC raised its position in Sherwin-Williams by 233.3% during the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company's stock worth $33,000 after buying an additional 77 shares during the last quarter. Anfield Capital Management LLC purchased a new position in Sherwin-Williams during the 2nd quarter worth approximately $38,000. Finally, Meeder Asset Management Inc. purchased a new position in Sherwin-Williams during the 2nd quarter worth approximately $41,000. 77.67% of the stock is owned by hedge funds and other institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.